Hyderabad-based Bharat Biotech has submitted data from Phase 3 clinical trials of BBV154, its intranasal Covid vaccine candidate, to the drug regulator.
The central government has decided to offer the use of the Indigenous 5G Test Bed free of cost to the Government recognized start-ups and MSMEs for the next six months up to January 2023.
EXAMIANS